J&J's Patent Suit Against Boston Scientific Heads To Jury

Law360, New York (June 21, 2005, 12:00 AM EDT) -- Johnson & Johnson’s closely watched patent infringement lawsuit against rival Boston Scientific Corp. over drug-coated stents has gone to the jury following closing arguments on Monday.

In closing arguments, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson’s groundbreaking invention of stenting technology “revolutionized cardiology.”

Diskant claimed Boston Scientific sought a “free ride” on his client's stent innovations by using the technology without permission since 1995.

“You have to pay for the ideas you take,”Diskant said.

Kirkland & Ellis partner John Desmarais, who...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.